HK1068375A1 - Method of determining dihydropyrimidine dehydrogenase gene expression - Google Patents

Method of determining dihydropyrimidine dehydrogenase gene expression

Info

Publication number
HK1068375A1
HK1068375A1 HK05100474A HK05100474A HK1068375A1 HK 1068375 A1 HK1068375 A1 HK 1068375A1 HK 05100474 A HK05100474 A HK 05100474A HK 05100474 A HK05100474 A HK 05100474A HK 1068375 A1 HK1068375 A1 HK 1068375A1
Authority
HK
Hong Kong
Prior art keywords
gene expression
dehydrogenase gene
dihydropyrimidine dehydrogenase
determining
determining dihydropyrimidine
Prior art date
Application number
HK05100474A
Other languages
English (en)
Inventor
Kathleen D Danenberg
Original Assignee
Response Genetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/796,807 external-priority patent/US6956111B2/en
Application filed by Response Genetics Inc filed Critical Response Genetics Inc
Publication of HK1068375A1 publication Critical patent/HK1068375A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
HK05100474A 2001-03-02 2005-01-18 Method of determining dihydropyrimidine dehydrogenase gene expression HK1068375A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US09/796,807 US6956111B2 (en) 2001-03-02 2001-03-02 Method of determining dihydropyrimidine dehydrogenase gene expression
US09/842,111 US6905821B2 (en) 2001-03-02 2001-04-26 Method of determining Dihydropyrimidine dehydrogenase gene expression
US09/879,217 US7005278B2 (en) 2001-03-02 2001-06-13 Method of determining dihydropyrimidine dehydrogenase gene expression
PCT/US2002/005221 WO2002070750A2 (en) 2001-03-02 2002-02-22 Method of determining dihydropyrimidine dehydrogenase gene expression

Publications (1)

Publication Number Publication Date
HK1068375A1 true HK1068375A1 (en) 2005-04-29

Family

ID=27419931

Family Applications (1)

Application Number Title Priority Date Filing Date
HK05100474A HK1068375A1 (en) 2001-03-02 2005-01-18 Method of determining dihydropyrimidine dehydrogenase gene expression

Country Status (15)

Country Link
US (1) US7005278B2 (de)
EP (1) EP1409723B1 (de)
JP (1) JP2005508603A (de)
CN (1) CN1250744C (de)
AR (1) AR032917A1 (de)
AT (1) ATE339521T1 (de)
AU (1) AU2002238115B2 (de)
CA (1) CA2439313C (de)
DE (1) DE60214725T2 (de)
HK (1) HK1068375A1 (de)
IL (1) IL157694A0 (de)
MX (1) MXPA03007884A (de)
NZ (1) NZ528374A (de)
TW (1) TWI274076B (de)
WO (1) WO2002070750A2 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020142328A1 (en) 2000-12-01 2002-10-03 Danenberg Kathleen D. Method of determining a chemotherapeutic regimen by assaying gene expression in primary tumors
EP1510588B1 (de) * 2003-08-28 2007-01-31 Roche Diagnostics GmbH Abhängigkeit des symptomfreien Überlebens 5-FU behandelter Darmkrebspatienten vom Verhältnis der mRNA-Expressionshöhe aus Thymidinphosphorylase und Dihydropyrimidindehydrogenase
US7449184B2 (en) 2005-01-21 2008-11-11 Genentech, Inc. Fixed dosing of HER antibodies
PT1850874E (pt) * 2005-02-23 2013-12-02 Genentech Inc Extensão de tempo até a progressão da doença ou sobrevivência em pacientes com cancro de ovário usando pertuzumab
JP2006316040A (ja) 2005-05-13 2006-11-24 Genentech Inc Ｈｅｒｃｅｐｔｉｎ（登録商標）補助療法
US8440398B2 (en) * 2006-01-25 2013-05-14 Taiho Pharmaceutical Co., Ltd. Method for prediction of sensitivity to 5-fluorouracil-type anticancer agent
PE20090681A1 (es) 2007-03-02 2009-06-10 Genentech Inc Prediccion de respuesta a un inhibidor her
US9551033B2 (en) * 2007-06-08 2017-01-24 Genentech, Inc. Gene expression markers of tumor resistance to HER2 inhibitor treatment
CA2690334C (en) 2007-06-08 2017-02-14 Genentech, Inc. Gene expression markers of tumor resistance to her2 inhibitor treatment
CA2691209A1 (en) 2007-06-22 2008-12-31 Kathleen Danenberg Methods for isolating long fragment rna from fixed samples
BRPI0812682A2 (pt) 2008-06-16 2010-06-22 Genentech Inc tratamento de cáncer de mama metastático
ES2572728T3 (es) 2009-03-20 2016-06-02 F. Hoffmann-La Roche Ag Anticuerpos anti-HER biespecíficos
JP5705836B2 (ja) 2009-05-29 2015-04-22 エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト Ｈｅｒ２を発現する胃癌患者のｈｅｒ２シグナル伝達のためのモジュレーター
US8079170B2 (en) * 2009-08-28 2011-12-20 Loftin Thomas E Gun barrel cleaning apparatus and method
US9556249B2 (en) 2010-02-18 2017-01-31 Genentech, Inc. Neuregulin antagonists and use thereof in treating cancer
WO2011146568A1 (en) 2010-05-19 2011-11-24 Genentech, Inc. Predicting response to a her inhibitor
US20130245233A1 (en) 2010-11-24 2013-09-19 Ming Lei Multispecific Molecules
EP2655413B1 (de) 2010-12-23 2019-01-16 F.Hoffmann-La Roche Ag Polypeptid-polynukleotid-komplex und verwendung bei der gezielten effektorrest-bereitstellung
KR20140057326A (ko) 2011-08-17 2014-05-12 제넨테크, 인크. 뉴레귤린 항체 및 그의 용도
WO2013063229A1 (en) 2011-10-25 2013-05-02 The Regents Of The University Of Michigan Her2 targeting agent treatment in non-her2-amplified cancers having her2 expressing cancer stem cells
RU2019103083A (ru) 2011-11-30 2019-03-22 Дженентек, Инк. МУТАЦИИ ErbB3 ПРИ РАКЕ
US9376715B2 (en) 2011-12-09 2016-06-28 Roche Molecular Systems, Inc Methods for detecting mutations in the catalytic subunit of the phosphoinositol-3 kinase (PIK3CA) gene
EP2831115A1 (de) 2012-03-27 2015-02-04 F. Hoffmann-La Roche AG Diagnose und behandlungen im zusammenhang mit her3-hemmern
BR112015012644A2 (pt) 2012-11-30 2017-12-19 Hoffmann La Roche método para determinar a necessidade de um paciente com câncer, método de tratamento do câncer, composição farmacêutica, uso de um ácido nucleico ou anticorpo e kit;
EP3454863A1 (de) 2016-05-10 2019-03-20 INSERM (Institut National de la Santé et de la Recherche Médicale) Kombinationstherapien zur behandlung von krebs

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4830969A (en) * 1981-08-31 1989-05-16 The Research Foundation Of State University Of New York Process for the rapid and simple isolation of nucleic acids
US4843155A (en) * 1987-11-19 1989-06-27 Piotr Chomczynski Product and process for isolating RNA
US5128247A (en) * 1989-08-14 1992-07-07 Board Of Regents, The University Of Texas System Methods for isolation of nucleic acids from eukaryotic and prokaryotic sources
US5620852A (en) * 1990-11-14 1997-04-15 Hri Research, Inc. Nucleic acid preparation methods
US5284940A (en) * 1990-11-14 1994-02-08 Hri Research, Inc. Preparation for nucleic acid samples
US5654179A (en) * 1990-11-14 1997-08-05 Hri Research, Inc. Nucleic acid preparation methods
US5346994A (en) * 1992-01-28 1994-09-13 Piotr Chomczynski Shelf-stable product and process for isolating RNA, DNA and proteins
US5502166A (en) * 1992-02-26 1996-03-26 Mitsubishi Chemical Corporation NMDH receptor proteins and genes encoding the same
WO1994018156A1 (en) * 1993-02-01 1994-08-18 University Of Iowa Research Foundation Quartenary amine surfactants and methods of using same in isolation of rna
US5637687A (en) * 1993-08-31 1997-06-10 Wiggins; James C. Methods and compositions for isolating nucleic acids
AU2289495A (en) 1994-04-13 1995-11-10 Uab Research Foundation, The Dihydropyrimidine dehydrogenase compositions and methods of use
US5643767A (en) * 1994-05-02 1997-07-01 The Rockefeller University Process for isolating cellular components
CA2153215A1 (en) * 1994-07-06 1996-01-07 Lu Wang Treatment of paraffin embedded tissue for gene analysis
US5856454A (en) 1994-09-12 1999-01-05 The United States Of America As Represented By The Department Of Health And Human Services CDNA for human and pig dihydropyrimidine dehydrogenase
US5707802A (en) * 1995-01-13 1998-01-13 Ciba Corning Diagnostics Corp. Nucleic acid probes for the detection and identification of fungi
US5777099A (en) * 1995-02-24 1998-07-07 Biotecx Laboratories, Inc. RNA separation
US5945515A (en) 1995-07-31 1999-08-31 Chomczynski; Piotr Product and process for isolating DNA, RNA and proteins
DE29601618U1 (de) * 1996-01-31 1996-07-04 Invitek Gmbh Vorrichtung zur gleichzeitigen multiplen Isolierung
EP0791654A1 (de) * 1996-02-21 1997-08-27 Jürgen A. Dr. Richt Polypeptide, die Aminosäuresequenzen der p57 oder p9.5 Proteine aus Borna-Krankheit Virus entsprechen, dafür kodierende Nukleinsäurefragmente und ihre Verwendung zu Diagnose- und Immunisierungzwecke
DK0896629T3 (da) 1996-03-20 2003-02-03 Us Gov Health & Human Serv Fremgangsmåder og præparater til påvisning af splejsningsdefekter i dihydropyrimidindehydro-genasegenet
CA2253937A1 (en) * 1996-05-10 1997-11-20 Phylomed Corporation Methods for oxidizing disulfide bonds using ozone
AU6764398A (en) 1997-03-20 1998-10-12 Variagenics, Inc. Target genes for allele-specific drugs
IT1302026B1 (it) 1997-08-22 2000-07-20 Hoffmann La Roche Materiali immunologici e metodi per la rivelazione di diidropirimidinadeidrogenasi.
US5952202A (en) * 1998-03-26 1999-09-14 The Perkin Elmer Corporation Methods using exogenous, internal controls and analogue blocks during nucleic acid amplification
AR031457A1 (es) 2000-12-01 2003-09-24 Response Genetics Inc Metodo para determinar un regimen terapeutico mediante el analisis de la expresion genica en tumores primarios
CA2436910C (en) * 2000-12-01 2014-06-17 Response Genetics, Inc. Method of determining epidermal growth factor receptor and her2-neu gene expression and correlation of levels thereof with survival rates

Also Published As

Publication number Publication date
US7005278B2 (en) 2006-02-28
CA2439313A1 (en) 2002-09-12
CN1518603A (zh) 2004-08-04
IL157694A0 (en) 2004-03-28
AU2002238115B2 (en) 2007-06-14
NZ528374A (en) 2008-01-31
TWI274076B (en) 2007-02-21
DE60214725D1 (de) 2006-10-26
EP1409723B1 (de) 2006-09-13
MXPA03007884A (es) 2004-10-15
DE60214725T2 (de) 2007-09-06
CN1250744C (zh) 2006-04-12
ATE339521T1 (de) 2006-10-15
WO2002070750A3 (en) 2004-02-19
US20030165840A1 (en) 2003-09-04
AR032917A1 (es) 2003-12-03
CA2439313C (en) 2012-08-07
JP2005508603A (ja) 2005-04-07
EP1409723A2 (de) 2004-04-21
WO2002070750A2 (en) 2002-09-12

Similar Documents

Publication Publication Date Title
HK1068375A1 (en) Method of determining dihydropyrimidine dehydrogenase gene expression
HK1085244A1 (en) Quantification of gene expression
IL160630A0 (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
IL160648A0 (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
HK1076771A1 (en) Method for making an article of unitary construction
AU2002302243A1 (en) Method for determination of co-occurences of attributes
AU2002350332A1 (en) Methods of parallel gene cloning and analysis
AU2003287254A1 (en) Inhibition of gene expression using rna interfering agents
AU2003267036A8 (en) Tubulysin biosynthesis gene
AU2003299864A8 (en) Sirna compounds and methods for the downregulation of gene expression
AU2003260945A1 (en) Methods of use for thermostable rna ligases
GB0416516D0 (en) Method of transducing es cells
GB0123401D0 (en) Methods of inducing gene expression
EP1384782A4 (de) Nachweisverfahren für die expression eines aspergillus-gens
AU2261802A (en) Method of analyzing gene expression
AU2002222618A1 (en) Method of analyzing gene expression
IL158004A0 (en) Method of enhancing entomophilous
AU2002359403A8 (en) Methods and compositions for regulation of gene expression through modulation of mrna turnover
HK1097571A1 (en) Method of determining dihydropyrimidine dehydrogenase gene expression
IL162481A0 (en) Method and use of determining genotype
AU2002349681A1 (en) Method of determining cationic surfactant
AU2002342417A1 (en) Inhibitors of dna methyltransferase isoforms
EP1454982A4 (de) Verfahren zur genexpressionsanalyse
EP1677665A4 (de) Bestimmung von ionen mit ionensensitiven enzymen
AU2002361399A8 (en) Method for the quantitative determination of gene expression

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20150222